Every effective medication has side effects — testosterone is no exception. But there is a vast difference between "has side effects" and "is dangerous." Most side effects of testosterone replacement therapy (TRT) are predictable, monitorable, and treatable — as long as they are caught early.
In this article, we explain each relevant side effect: how common it is, why it happens, how it manifests, and what your doctor does about it. No trivializing, no fear-mongering — just facts.
The Most Important Rule First
Side effects on TRT are almost always a dosing problem, not a fundamental problem with testosterone itself. If the dose is too high, side effects increase. If the dose is properly adjusted and regularly monitored, most men are symptom-free.
The Endocrine Society therefore recommends in its 2018 guidelines that every TRT regimen must be accompanied by a structured monitoring plan [1].
Side Effect 1: Blood Thickening (Erythrocytosis)
What Happens?
Testosterone stimulates red blood cell production. This is actually desirable — more red blood cells mean better oxygen delivery, more energy, better physical performance. But when the blood becomes too thick, the risk of blood clots increases.
How Common?
This is the most frequent side effect by far. Depending on the study and formulation, it affects 5–20% of patients [2]:
| Formulation | Frequency of Elevated Blood Values |
|---|---|
| Injections (e.g. testosterone enanthate) | Higher (peak levels after injection) |
| Gel (daily application) | Lower (more stable levels) |
| Nasal spray | Lowest |
How Do You Notice It?
Most of the time, you notice nothing at all. That is precisely why blood count monitoring is essential. Possible signs at severely elevated levels:
- Headaches
- Facial flushing
- Dizziness
- Tingling in the fingers
What Does the Doctor Do?
- Check blood count every 3–6 months (hematocrit value)
- If slightly elevated: reduce dose or switch to gel
- If significantly elevated: therapeutic phlebotomy (blood donation) — a simple and effective method to reduce blood viscosity
The TRAVERSE trial (2023) showed that fewer than 1% of participants reached a critically elevated hematocrit [3]. With regular monitoring, this side effect is well controlled.
Side Effect 2: Estrogen Conversion and Breast Tissue Swelling
What Happens?
The body automatically converts a portion of testosterone into estrogen via an enzyme called aromatase. This is a normal physiological process. It becomes problematic when too much is converted:
- Breast tissue swelling (gynecomastia) — the chest becomes tender or visibly enlarged
- Fluid retention — hands, feet, or face appear puffy
- Mood swings — irritability or emotional instability
How Common?
Approximately 10–25% of men on TRT experience some degree of breast tenderness. Visible enlargement is less common — affecting perhaps 5–10% [4].
When Is It Most Likely?
- In overweight men — adipose tissue contains more aromatase
- At high testosterone doses — more substrate available for conversion
- With injections — post-injection testosterone peaks can accelerate conversion
What Does the Doctor Do?
- Measure estrogen levels in blood work (every 3–6 months)
- Adjust dose — a reduction often suffices
- If necessary: prescribe an aromatase inhibitor (e.g. low-dose anastrozole)
- Recommend weight loss — less fat = less conversion
Side Effect 3: Skin Changes and Acne
What Happens?
Testosterone increases sebaceous gland activity in the skin. The result: oilier skin, potentially clogged pores, and in some cases acne — particularly on the back, shoulders, and face.
How Common?
Acne on TRT is relatively common but rarely severe. Studies report that up to 30% of patients notice increased skin oiliness or mild breakouts. Severe, scarring acne is very rare at medical TRT doses (in contrast to anabolic steroid abuse) [5].
What Helps?
- Skin care: Daily cleansing with a gentle face wash
- Benzoyl peroxide or salicylic acid — available over the counter
- For more severe cases: prescription topical treatments or antibiotic gel
- Dose adjustment: Skin often clears when the dose is slightly reduced
- Acne improves in most patients after 6–12 months, once the body adjusts to the new hormone levels
Side Effect 4: Suppression of Sperm Production
What Happens?
When testosterone is administered externally, the body signals the testes: "Sufficient testosterone is present — reduce endogenous production." This suppresses not only testosterone synthesis but also sperm production — sometimes to a complete halt.
Is This Permanent?
How are your testosterone levels?
Our doctor-developed self-test shows you in 4 minutes whether an evaluation could be useful — free and anonymous.
In the vast majority of cases: No. After discontinuation, sperm production recovers fully in most men [6]:
- 67% within 6 months
- 90% within 12 months
- 100% within 24 months
What If You Want Children?
If fertility is a current or future consideration, proven alternatives exist:
- HCG alongside TRT — keeps the testes active and maintains sperm production
- Clomiphene instead of TRT — raises endogenous testosterone without suppressing sperm
- Pause TRT and switch to HCG + clomiphene when actively trying to conceive
Discuss family planning with your doctor before starting TRT — not when you are already trying to conceive.
Side Effect 5: Sleep Apnea
What Happens?
TRT can worsen pre-existing obstructive sleep apnea. In men without prior history, TRT-induced onset is unlikely but possible — especially in overweight individuals.
How Common?
The Endocrine Society classifies the risk as low to moderate [1]. It primarily affects men with existing risk factors:
- Obesity (BMI > 30)
- Neck circumference > 43 cm (17 inches)
- Known snoring or daytime somnolence
What Does the Doctor Do?
- Before therapy: Screen for snoring, daytime fatigue, observed breathing pauses
- During therapy: If sleep quality deteriorates or daytime fatigue worsens, refer for sleep evaluation
- If sleep apnea is confirmed: treat with CPAP — TRT does not necessarily need to be discontinued
Side Effect 6: Testicular Atrophy
What Happens?
When the body no longer receives signals to produce its own testosterone, the testes receive less stimulation and can shrink in size. This is the same mechanism underlying sperm suppression — reduced gonadotropin drive.
How Common?
It affects a substantial proportion of patients — estimates range from 30–50%, though the extent is usually minor (a few millimeters). Many men do not notice it.
What Helps?
- HCG administration (2–3 times per week, subcutaneous injection) keeps the testes active and largely prevents atrophy
- If TRT is discontinued, testicular size typically recovers
The Monitoring Plan: How Your Doctor Keeps You Safe
Well-managed TRT without regular blood checks is like driving without a dashboard — it can go well, but it does not have to. The guidelines [1] recommend:
| Period | Interval | What Is Monitored |
|---|---|---|
| Before starting | Baseline | Testosterone (2×), SHBG, LH, FSH, CBC, liver, kidney, lipids, PSA, estrogen |
| Years 1–2 | Every 3 months | Testosterone (trough), hematocrit, estrogen, PSA |
| From year 3 | Every 6 months | Testosterone, hematocrit, estrogen, PSA, lipid profile |
| Annually | Additionally | Complete blood count, lipid panel, PSA, DXA if osteoporosis risk |
When Should You Reconsider Therapy?
TRT should be paused or discontinued if:
- Hematocrit remains persistently above 54% despite dose adjustment
- Severe, untreated sleep apnea is present
- Active prostate cancer is diagnosed
- Severe side effects occur that do not respond to dose modification
In the vast majority of cases, a dose adjustment or formulation change is sufficient — complete discontinuation is rarely necessary.
FAQ
What is the most common side effect of TRT? Erythrocytosis — an increase in red blood cell production that thickens the blood. It affects 5–20% of patients depending on the formulation used [2]. Through regular blood count monitoring (every 3–6 months) and dose adjustment or therapeutic phlebotomy if needed, it is well controlled.
Does TRT cause breast enlargement in men? In approximately 5–10% of cases, visible breast tissue swelling (gynecomastia) can occur, as the body converts some testosterone to estrogen [4]. The likelihood increases with excess body weight and higher doses. If necessary, an aromatase inhibitor can be prescribed.
Are TRT side effects permanent? No — the vast majority of side effects are reversible and dose-dependent. Acne, erythrocytosis, and testicular atrophy resolve after dose adjustment or discontinuation. Sperm production also recovers in over 90% of men within 12 months [6].
How often do you need blood tests on TRT? The Endocrine Society recommends: every 3 months during the first two years, then every 6 months. Tests include testosterone (trough level), hematocrit, estrogen, and PSA. From year 3 onward, annual comprehensive blood work and lipid panels are added [1].
Conclusion
TRT has side effects — that is honest and important to acknowledge. But the good news: nearly all side effects are predictable, measurable, and treatable. The key lies in an experienced physician who knows what to monitor and in regular blood work.
The most common "side effect" of untreated testosterone deficiency, incidentally, is this: living for years with fatigue, lack of motivation, and diminished quality of life — when a straightforward treatment exists.
Further Reading

Specialist in General Internal Medicine · Medical Director
This article was medically reviewed by Dr. Ramadan for accuracy. It is based on current research and international guidelines.
Your Next Step
You've informed yourself — now you can find out in 4 minutes whether a medical evaluation makes sense for you.
Sources
- [1]Bhasin S et al. (2018). Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. *J Clin Endocrinol Metab*, 103(5), 1715–1744
- [2]Cervi A, Balitsky AK (2024). Testosterone therapy-induced erythrocytosis: can phlebotomy be justified? *Endocrine Connections*, 13(12), e240283
- [3]Lincoff AM et al. (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. *N Engl J Med*, 389(2), 107–117
